萬維書刊網微信二維碼

掃微信,關注編輯QQ!

您的位置:萬維書刊網 >>sci/scie期刊 >>醫藥衛生>>傳染免疫學

HIV Clinical Trials(研究方向:傳染病學) (官網投稿)

簡介
  • 期刊簡稱待設置
  • 參考譯名待設置
  • 核心類別 外文期刊,
  • IF影響因子待設置
  • 自引率待設置
  • 主要研究方向待設置

主要研究方向:

等待設置主要研究方向
待設置

HIV Clinical Trials(雙月刊),創刊于2000年,出版國家為美國,是專門專門以跟蹤艾滋病毒/艾滋病臨床研究的最新進展,可通過雜志獲得更全面的全球發展情況。
征稿信息

萬維提示:

1、投稿方式:在線投稿。

2、期刊官網:

http://www.tandfonline.com/loi/yhct20

3、期刊投稿:

http://www.edmgr.com/hct/default.aspx

4、信息說明:本刊信息來源于網絡,包括 SCI 收錄核心期刊,增補期刊,期刊收錄數據每年進行更新。本站是公益性網站,為網友投稿提供免費服務,由于受相關約束,我們不能提供相關期刊的影響因子、JCR期刊分區等數據供大家參考,造成不便,敬請諒解。

2017526日星期五

                          

 

Author Guidelines

 

About the journal

 

HIV Clinical Trials is an international, peer reviewed journal, publishing high-quality, original research. Please see the journal’s Aims & Scope for information about its focus and peer-review policy.

 

Please note that this journal only publishes manuscripts in English.

 

Peer review

 

Taylor & Francis is committed to peer-review integrity and upholding the highest standards of review. Once your paper has been assessed for suitability by the editor, it will then be double blind peer-reviewed by independent, anonymous expert referees. Find out more about what to expect during peer review and read our guidance on publishing ethics.

 

Preparing your paper

 

All authors submitting to medicine, biomedicine, health sciences, allied and public health journals should conform to the Uniform Requirements for Manuscripts Submitted to Biomedical Journals, prepared by the International Committee of Medical Journal Editors (ICMJE).

 

Word count

 

Please include a word count for your paper. A typical paper for this journal should not exceed 4000 words; inclusive of tables, references, figure captions.

 

Style guidelines

 

Please refer to these quick style guidelines when preparing your paper, rather than any published articles or a sample copy.

 

Please use American spelling consistently throughout your manuscript.

 

Please use single quotation marks, except where ‘a quotation is “within” a quotation’. Please note that long quotations should be indented without quotation marks.

 

Formatting and templates

 

Papers may be submitted in any standard format, including Word and LaTeX. Figures should be saved separately from the text. To assist you in preparing your paper, we provide formatting template(s).

 

Word templates are available for this journal. Please save the template to your hard drive, ready for use.

 

If you are not able to use the templates via these links (or if you have any other template queries) please contact [email protected]

 

References

 

Please use this reference guide when preparing your paper.

 

Checklist: what to include

 

Author details. Please include all authors’ full names, affiliations, postal addresses, telephone numbers and email addresses on the cover page. Where available, please also include ORCiDs and social media handles (Facebook, Twitter or LinkedIn). One author will need to be identified as the corresponding author, with their email address normally displayed in the article PDF (depending on the journal) and the online article. Authors’ affiliations are the affiliations where the research was conducted. If any of the named co-authors moves affiliation during the peer-review process, the new affiliation can be given as a footnote. Please note that no changes to affiliation can be made after your paper is accepted. Read more on authorship.

A structured abstract of 250 words. A structured abstract should cover (in the following order) Background; Objective; Methods; Results; Conclusions.

Read tips on writing your abstract.

Graphical abstract. This is an image to give readers a clear idea of the content of your article. It should be a maximum width of 525 pixels. If your image is narrower than 525 pixels, please place it on a white background 525 pixels wide to ensure the dimensions are maintained. Save the graphical abstract as a .jpg, .png, or .gif. Please do not embed it in the manuscript file but save it as a separate file, labelled GraphicalAbstract1.

You can opt to include a video abstract with your article. Find out how these can help your work reach a wider audience, and what to think about when filming.

7 keywords. Read making your article more discoverable, including information on choosing a title and search engine optimization.

Funding details. Please supply all details required by your funding and grant-awarding bodies as follows:

For single agency grants

This work was supported by the under Grant .

For multiple agency grants

This work was supported by the <> under Grant ; > under Grant ; and under Grant .

 

Disclosure statement. This is to acknowledge any financial interest or benefit that has arisen from the direct applications of your research. Further guidance on what is a conflict of interest and how to disclose it.

Biographical note. Please supply a short biographical note for each author. This could be adapted from your departmental website or academic networking profile and should be relatively brief (e.g. no more than 200 words).

Geolocation information. Submitting a geolocation information section, as a separate paragraph before your acknowledgements, means we can index your paper’s study area accurately in JournalMap’s geographic literature database and make your article more discoverable to others. More information.

Supplemental online material. Supplemental material can be a video, dataset, fileset, sound file or anything which supports (and is pertinent to) your paper. We publish supplemental material online via Figshare. Find out more about supplemental material and how to submit it with your article.

Figures. Figures should be high quality (1200 dpi for line art, 600 dpi for grayscale and 300 dpi for colour). Figures should be saved as TIFF, PostScript or EPS files.

Tables. Tables should present new information rather than duplicating what is in the text. Readers should be able to interpret the table without reference to the text. Please supply editable files.

Equations. If you are submitting your manuscript as a Word document, please ensure that equations are editable. More information about mathematical symbols and equations.

Units. Please use SI units (non-italicized).

Using third-party material in your paper

 

If you wish to include any material in your paper for which you do not hold copyright, you will need to obtain written permission from the copyright owner prior to submission. More information on requesting permission to reproduce work(s) under copyright.

 

Declaration of interest

 

Please include a declaration of interest statement, using the subheading "Declaration of interest." If you have no interests to declare, please state this (suggested wording: The authors report no declarations of interest). For all NIH/Wellcome-funded papers, the grant number(s) must be included in the declaration of interest statement. Read more on declaring conflicts of interest.

 

Clinical Trials Registry

 

In order to be published in a Taylor & Francis journal, all clinical trials must have been registered in a public repository at the beginning of the research process (prior to patient enrolment). Trial registration numbers should be included in the abstract, with full details in the methods section. The registry should be publicly accessible (at no charge), open to all prospective registrants, and managed by a not-for-profit organization. For a list of registries that meet these requirements, please visit the WHO International Clinical Trials Registry Platform (ICTRP). The registration of all clinical trials facilitates the sharing of information among clinicians, researchers, and patients, enhances public confidence in research, and is in accordance with the ICMJE guidelines.

 

Complying with ethics of experimentation

 

Please ensure that all research reported in submitted papers has been conducted in an ethical and responsible manner, and is in full compliance with all relevant codes of experimentation and legislation. All papers which report in vivo experiments or clinical trials on humans or animals must include a written statement in the Methods section. This should explain that all work was conducted with the formal approval of the local human subject or animal care committees (institutional and national), and that clinical trials have been registered as legislation requires. Authors who do not have formal ethics review committees should include a statement that their study follows the principles of the Declaration of Helsinki.

 

Consent

 

All authors are required to follow the ICMJE requirements on privacy and informed consent from patients and study participants. Please confirm that any patient, service user, or participant (or that person’s parent or legal guardian) in any research, experiment, or clinical trial described in your paper has given written consent to the inclusion of material pertaining to themselves, that they acknowledge that they cannot be identified via the paper; and that you have fully anonymized them. Where someone is deceased, please ensure you have written consent from the family or estate.

 

Health and safety

 

Please confirm that all mandatory laboratory health and safety procedures have been complied with in the course of conducting any experimental work reported in your paper. Please ensure your paper contains all appropriate warnings on any hazards that may be involved in carrying out the experiments or procedures you have described, or that may be involved in instructions, materials, or formulae.

Please include all relevant safety precautions; and cite any accepted standard or code of practice. Authors working in animal science may find it useful to consult the International Association of Veterinary Editors’ Consensus Author Guidelines on Animal Ethics and Welfare and Guidelines for the Treatment of Animals in Behavioural Research and Teaching. When a product has not yet been approved by an appropriate regulatory body for the use described in your paper, please specify this, or that the product is still investigational.

 

Submitting your paper

 

This journal uses Editorial Manager to manage the peer-review process. If you haven't submitted a paper to this journal before, you will need to create an account in Editorial Manager. Please read the guidelines above and then submit your paper in the relevant Author Centre, where you will find user guides and a helpdesk.

 

If you are submitting in LaTeX, please convert the files to PDF beforehand (you will also need to upload your LaTeX source files with the PDF).

 

Please note that HIV Clinical Trials uses Crossref? to screen papers for unoriginal material. By submitting your paper to HIV Clinical Trials you are agreeing to originality checks during the peer-review and production processes.

 

On acceptance, we recommend that you keep a copy of your Accepted Manuscript. Find out more about sharing your work.

 

編者

 

Alain Lafeuillade,總醫院(法國土倫,馬里蘭大學醫學院,美國馬里蘭大學)  [email protected]

Caroline A Sabin,(英國倫敦大學學院)  [email protected]

David Hardy(美國惠特曼沃克健康)[email protected]

創始總編輯:艾滋病毒臨床試驗

Maurice J Staquet,(布魯塞爾自由大學醫學院,比利時)

編委會

 

Judith A. Aberg(伊坎醫學院,西奈山,紐約州,美國)

日本日本國際醫療中心艾滋病臨床中心青野洋子

大衛·阿博(David Asboe),(英國的圣斯蒂芬中心,切爾西和威斯敏斯特醫院)

丹麥哥本哈根大學醫院感染性疾病部門的Thomas Benfield博士

佩德羅·卡恩(阿根廷基輔基金會)

(澳大利亞艾滋病毒流行病學和臨床研究國家中心圣文森特醫院的Andrew Carr

JoséL Casado(西班牙Ramon y Cajal醫院傳染病部)

P Dellamonica,(法國馬德里傳染病和熱帶病,H?pitalArchet,法國)

Jose M Gatell(西班牙巴塞羅那大學醫院診所傳染病科)

Roy Gulick,(威爾醫學院,康奈爾大學,紐約州,美國)

Quarraisha Abdool Karim(哥倫比亞大學南非Fogarty艾滋病毒/艾滋病/結核病研究培訓計劃/納爾遜·曼德拉醫學院,南非納塔勒大學)

David Katzenstein(美國加利福尼亞州斯坦福大學傳染病科)

Stephen Kravcik(加拿大渥太華醫院綜合醫學科)

Julio MontanerBC卑詩省艾滋病毒/艾滋病卓越中心,加拿大卑詩省不列顛哥倫比亞大學)

Miros Opravil(瑞士蘇黎世大學)

L Perrin(瑞士日內瓦大學醫院傳染病科)

Praphan Phanuphak,(朱拉隆功大學醫學院/泰國紅十字會艾滋病研究中心/ HIV-NAT曼谷泰國)

Dennis A Revicki(美國生物資源公司聯合研究中心)

JürgenRockstroh(德國波恩大學醫院醫學部)

(傳染病部,法國羅斯柴爾德醫院)Willy W Rozenbaum

科萊特史密斯(英國倫敦大學學院)

Jose A Vazquez(美國密歇根州韋恩州立大學醫學院亨利福特醫院傳染病科)

Stefano Vella,(意大利維多利亞州立大學病毒學實驗室)

(英國皇家自由醫院艾滋病毒醫學皇家免費中心)Mike Youle


投稿問答最小化  關閉

曾道人黄金资料118